Tag: Patient Safety

ECRI announces 2022 Safety Excellence Award winner

Editor's Note ECRI and the Institute for Safe Medication Practices PSO, on November 7, named Monument Health of Rapid City, South Dakota, the winner of the 2022 Safety Excellence Award. The healthcare system set a strategic goal to improve culture of safety, increase incident and near-miss event reporting, and enrich…

Read More

By: Judy Mathias
November 7, 2022
Share

Complexity, challenges of diagnosis, management of long COVID

Editor's Note This study led by researchers at the VA Puget Sound Health Care System and University of Washington, Seattle, highlights the complexity of diagnosing long COVID and the challenges of caring for patients with this condition. Included in the analysis were 200 randomly sampled COVID-19 patients receiving care in…

Read More

By: Judy Mathias
November 3, 2022
Share

FDA: Class I recall of Teleflex Iso-Gard Filter S

Editor's Note The Food and Drug Administration (FDA) on November 1 identified the recall of Teleflex’s Iso-Gard Filter S as Class I, the most serious. Iso-Gard filters are breathing circuit bacterial filters that are connected to respiratory equipment or breathing systems in operating rooms and ICUs. The recall was initiated…

Read More

By: Judy Mathias
November 3, 2022
Share

Wildfire smoke linked to adverse events in pediatric patients under anesthesia

Editor's Note This study from the University of California San Francisco finds that pediatric patients with risk factors for respiratory complications had a greater incidence of adverse events under general anesthesia during periods of unhealthy air quality caused by wildfire smoke. A total of 625 pediatric patients were included in…

Read More

By: Judy Mathias
November 2, 2022
Share

FDA issues Safety Communication on tracheostomy tube shortages

Editor's Note The Food and Drug Administration (FDA) on October 31 issued a Medical Device Safety Communication on tracheostomy tube shortages. Included in the shortages are Bivona tracheostomy tubes manufactured by ICU Medical, which are more likely to affect pediatric patients. Also on the shortage list are JOH Tube Tracheostomy…

Read More

By: Judy Mathias
November 2, 2022
Share

FDA: Five companies are having amoxicillin shortages

Editor's Note As of November 1, the Food and Drug Administration (FDA) listed 26 amoxicillin products on its current drug shortages site. The FDA says increased demand is the largest cause of the shortage. The FDA does not list resupply dates, but the American Society of Health-System Pharmacists (ASHP) estimates…

Read More

By: Judy Mathias
November 1, 2022
Share

Reducing noise in the OR improves children’s postop behavior

Editor's Note Reducing noise in the OR positively affects children’s postoperative behavior, according to research presented October 24 at the Anesthesiology 2022 annual meeting in New Orleans. The study, led by researchers at Nationwide Children’s Hospital, Columbus, Ohio, included 64 preschool children (ages 4 to 5 years old) having general…

Read More

By: Judy Mathias
October 27, 2022
Share

The Joint Commission will resume certain intracycle calls

Editor's Note The Joint Commission announced on October 26 that it will resume intracycle calls for Disease-Specific Care (DSC) and Health Care Staffing Services (HCSS) certification programs, starting January 1, 2023. These calls, which were suspended in 2021 because of COVID-19, require programs to update their intracycle tabs in the…

Read More

By: Judy Mathias
October 27, 2022
Share

Variation in treatment, outcomes by race of veterans hospitalized with COVID-19

Editor's Note This study led by the University of Pittsburgh School of Medicine finds that Black veterans hospitalized with COVID-19 were less likely to be treated with evidence-based treatments than White patients. A total of 43,222 veterans (12,135 Black and 31,087 White) hospitalized with COVID-19 in 130 Veterans Affairs Medical…

Read More

By: Judy Mathias
October 26, 2022
Share

FDA: Class I recall of Jiangsu Well Biotech COVID-19 Ag Rapid Test

Editor's Note The Food and Drug Administration (FDA) on October 12 identified the recall of Jiangsu Well Biotech’s COVID-19 Ag Rapid Test Devices as Class I, the most serious. The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA. No…

Read More

By: Judy Mathias
October 26, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat